News

Even after several tests and being prescribed over 50 bottles of antibiotics, Jasper’s symptoms did not improve, leaving his ...
The debate continues over the potential of measurable residual disease to transform research and clinical care in hematology.
Adding polatuzumab vedotin to rituximab, gemcitabine, and oxaliplatin (R-GemOx) significantly improved overall survival in transplant-ineligible patients with relapsed/refractory diffuse large B-cell ...
MountainView Hospital is making history as the first hospital in Nevada to perform both CAR T-cell therapy and allogeneic ...
A 29-year-old man from Switzerland is back in Philadelphia at Penn Medicine months after having a life-changing double-hand transplant.
Cheryl Doyle, 51, is on daily dialysis to combat her donated kidney failing. Now she needs another—and a living donor this ...
Last fall, the 28-year-old came to the Hospital of the University of Pennsylvania from his home in Switzerland for a rare ...
Aftercare and Recovery: Postoperative care is not an afterthought. AHD Clinic provides clear instructions and prescribes ...
Advanced practice providers have the opportunity to instill hope in patients through education and personalized care.
Transplantation with standard-criteria kidney offers a clear survival benefit, but this decreases with age and for those with ...
"We get to the hospital and the next thing you know, the transplant happened," recalled Clark, who was at Huntington Hospital ...
Panelists discuss how treatment strategies differ between transplant-eligible and transplant-ineligible multiple myeloma patients, with transplant eligibility determined by functional status rather ...